GlobeNewswire

Le KFSH de Riyad obtient la distinction « Global Elite Five-Star » de Davos Healthcare et figure parmi les 5 % des hôpitaux les mieux évalués au monde
06/11/2026
RIYAD, Arabie saoudite, 06 nov. 2026 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre (KFSH) de Riyad s’est vu décerner la médaille « Global Elite Five-Star » par Davos Healthcare, la plus [...]
HCW Biologics’ Presentation for HCW11-040 Recognized for Scientific Rigor, Novelty, Clarity and Potential Impact on Cancer Immunotherapy by the Society for Immunotherapy of Cancer
06/11/2026
Designated as one of the Top 150 abstracts submitted for the 41 st Annual Meeting of the Society for Immunotherapy of Cancer HCW11-040 is a first-in-class, second-generation, tetravalent pembrolizumab (Keytruda®) based [...]
New phase 2 data highlight the strength of the immune response induced by personalized cancer vaccine EVX-01
06/11/2026
Detection of neoantigen-specific T cells directly ex vivo indicates strong EVX-01-induced immune responses Data further underlines the strong predictive performance of Evaxion’s AI-Immunology™ platform The new biomarker [...]
Fennec Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 12, 2026
06/11/2026
RESEARCH TRIANGLE PARK, N.C., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release [...]
Eccogene to Present Preclinical Data of Small Molecule Amylin and Calcitonin Receptor Agonist ECC1542 at ObesityWeek® 2026
06/11/2026
Poster presentation will highlight the preclinical profile of ECC1542 and its potential for treating obesity and associated comorbidities BOSTON and SHANGHAI, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Eccogene, a global [...]
EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meetings
06/11/2026
WATERTOWN, Mass., Nov. 06, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal [...]
Spectral Medical Announces Third Quarter 2026 Financial Results and Provides Corporate Update
06/11/2026
• Recent financing expected to fund operations through anticipated FDA PMA decision • Company to host a Corporate Update call December 10, 2026 TORONTO, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral [...]
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/11/2026
BEDFORD, Mass., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina experience, today [...]
Korro to Present at the 2026 Jefferies Global Healthcare Conference in London
06/11/2026
CAMBRIDGE, Mass., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company leveraging a novel Oligonucleotide Promoted Editing of RNA (OPERA ® ) platform to [...]
Fractyl Health to Report Third Quarter 2026 Financial Results and Provide Business Updates on November 12, 2026
06/11/2026
BURLINGTON, Mass., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company or Fractyl), a clinical-stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity [...]
Satellos Changes Primary Efficacy Endpoint in BASECAMP Phase 2 Pediatric Trial to MRI-Measured Fat Fraction Following FDA Feedback
06/11/2026
Fat fraction, together with clinical endpoints, may support a potential accelerated approval pathway for forazapadin Protocol amendment submitted to implement the new primary efficacy endpoint Topline 12-week placebo- [...]
What Do Healthcare Sharing Programs Actually Cover, and What They Don’t
06/11/2026
Eligibility guidelines are where healthcare sharing programs differ most, especially for pre-existing conditions, routine care, mental health, maternity, and prescriptions. WeShare Health begins sharing pre-existing [...]
Treace Announces First Surgical Cases with the Tailorplasty™ MIS Tailor’s Bunion Correction System
06/11/2026
New solution for 5ᵗʰ metatarsal deformities further broadens portfolio and provides access to incremental surgical procedures PONTE VEDRA, Fla., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” [...]
Anika Reports Third Quarter 2026 Financial Results
06/11/2026
Revenue Increased 10% Year Over Year, Led by 17% Commercial Channel Growth Including More Than 30% Growth in Integrity TM Revenue Secured New 10-Year Hyvisc® Partnership with Enhanced Economics; Reintroduced Hyaff Non- [...]
Treace Medical Concepts Reports Third Quarter 2026 Financial Results
06/11/2026
Achieved double digit procedure volume growth in the third quarter PONTE VEDRA, Fla., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology [...]
Arch Biopartners Arranges Non-Brokered Private Placement
06/11/2026
TORONTO, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Arch Biopartners Inc . (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that it has arranged a non-brokered private placement offering of 1,058, [...]
Can-Fite to Pursue Global Licensing and Strategic Partnerships at BIO-Europe 2026 Following Recent Clinical and Intellectual Property Milestones
06/11/2026
Company to leverage positive Phase IIa pancreatic cancer results presented at ESMO 2026, two pivotal Phase III programs, and expanding patent protection to advance global partnering opportunities RAMAT GAN, Israel, Nov [...]
Davion Healthcare Plc Appoints Vienna Capital Partners to Support US$100 Million Acquisition Financing Strategy
06/11/2026
Financial advisory appointment to support planned acquisitions of profitable, revenue-generating businesses during 2027 DUBLIN, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Davion Healthcare Plc (NASDAQ: DAVI) (“Davion” or the “ [...]
InflaRx Announces Publication of Phase 1 Data Demonstrating Favorable Safety and Pharmacokinetic/Pharmacodynamic Profile of Izicopan
06/11/2026
Izicopan achieved rapid and sustained inhibition of C5a/C5aR1 signaling Pharmacokinetic results demonstrated dose-dependent exposure, with izicopan well tolerated across all single and multiple doses evaluated Findings [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum